News + Resources
Innovations Advanced by M&A: New Treatment Options for Migraines
This blog is another installment in a series, Innovations Advanced by M&A, that underscores the importance of mergers and acquisitions in ensuring a competitive and vibrant biopharmaceutical landscape for patients. You can find previous blogs in this...
CBSA: Life Sciences M&A Fuels Growth & Innovation in Colorado
In a recent blog post, PULSE partner Colorado Bioscience Association (CBSA) highlighted the fundamental role of pro-innovation mergers and acquisitions in driving life sciences innovation and economic growth in Colorado and beyond. Read their blog post...
Latest Estimates Reinforce Burden of FTC’s Final HSR Rule
The Federal Trade Commission (FTC)’s recently finalized Hart-Scott-Rodino (HSR) premerger notification rule places a significant time and cost burden on companies engaging in procompetitive mergers and acquisitions (M&A), according to top legal analyses and the...
National Venture Capital Association: FTC’s Enforcement Approach is Chilling Critical Investment in New Breakthroughs
The Federal Trade Commission (FTC)’s aggressive approach to mergers and acquisitions enforcement (M&A) is disrupting critical investment in innovation, according to National Venture Capital Association (NVCA) President Bobby Franklin, in an interview with Axios....
What They Are Saying: FTC’s Final HSR Premerger Rules Place Undue Burden on Competitive M&A Across Life Sciences
Leading organizations are expressing concern about the impact of the Federal Trade Commission (FTC)’s final Hart-Scott-Rodino (HSR) premerger notification rule, including the chilling effect it could have on biopharmaceutical and life sciences innovation. While the...